Chemours (NYSE:CC – Get Rating) had its price target boosted by BMO Capital Markets from $54.00 to $64.00 in a research note released on Monday, The Fly reports. Several other research firms have also recently commented on CC. StockNews.com cut Chemours from a buy rating to a hold rating in a research note on Saturday, […]